# Green Arrow Capital

> Green Arrow Capital is a VC fund in Milan backing Health Care and Software. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Milan, Italy
- Total investments: 10
- Last investment: Jul 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/green-arrow-capital/
- X (Twitter): https://twitter.com/GA_Capital
- Website: http://greenarrow-capital.com

Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.

## Contacts

5 contacts available for Green Arrow Capital. Shizune tracks 3 team members at Green Arrow Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/quadrivio-sgr?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.5M–$2.2M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 30% |
| Software | 2 | 20% |
| Biotechnology | 2 | 20% |
| Manufacturing | 2 | 20% |
| Information Technology | 2 | 20% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 30% |
| Funding Round | 3 | 30% |
| Series A | 1 | 10% |
| Private Equity | 1 | 10% |
| Convertible Note | 1 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Italy | 8 | 80% |
| United Kingdom | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daniele Camponeschi | Co-Founder & Chief Investment Officer | 0 | https://shizune.co/investors/profile/daniele-camponeschi |
| Eugenio de Blasio | Founder, main shareholder and Group CEO | 0 | https://shizune.co/investors/profile/eugenio-de-blasio |
| Walter Ricciotti | Managing Director | 0 | https://shizune.co/investors/profile/walter-ricciotti |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Green Future Project | Green Future Project is a subscription platform for the earth. Their projects include land restoration and preservation, marine solutions, and renewable energy projects. | $535.1K | Convertible Note | Jul 28, 2022 |  |
| Maticmind S.p.A | Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators. |  | Private Equity | Aug 03, 2020 |  |
| Glomeria Therapeutics | Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy. | $1.1M |  | Sep 19, 2015 |  |
| Directa Plus | Directa Plus is a nanotechnology company, manufactures nanoparticles. | $6M |  | Apr 27, 2015 |  |
| Cogisen | Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy. | $1.5M | Series A | Oct 20, 2014 |  |
| Personal Factory | Personal Factory is a company that operates mainly in the chemical industry for the construction industry by providing chemical compound useful for the production of powder with the establishment Origami 4. Personal Factory, designing and realizing also the technological platform (Origami 4) and providing business consulting services and technical,branding, marketing and research laboratory work then no. | $2.2M |  | Jul 30, 2013 |  |
| Cogisen | Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy. | $2.2M | Series A | May 01, 2013 |  |
| Fluidotecnica Sanseverino | Fluidotecnica Sanseverino Srl develops Disolea, a system to separate all floating polluting fluids from the production process water. |  | Seed | Dec 01, 2012 |  |
| D-Orbit | D-Orbit is an Italian New Space company providing solutions for satellite design, development, launch, commissioning and decommissioning. Founded in 2011, D-Orbit currently employs approximately 35 people. The firm is based in Milan, Italy with subsidiaries in Washington, DC, and Lisbon, Portugal. D-Orbit's business model revolves aroundproducts and services that are profitable, create value for the customer, and have a proven social benefit and a positive impact on the environment. To do so, we look for ways to streamline every phase of a satellite mission with components and services that simplify spacecraft design, increase reliability, improve the use of mission resources, reduce operational costs, and extend the revenue-generating phase of a space mission. | $2.5M | Seed | Jul 01, 2012 |  |
| BIOUNIVERSA srl | BIOUNIVERSA srl, a biotechnology company, develops diagnostic and therapeutic products based on biological properties of the BAG3 protein on cell death regulation. |  | Seed | Nov 01, 2010 |  |

10 of 10 investments shown.

## Co-investors
- [Vertis](https://shizune.co/investors/profile/vertis-sgr-s-p-a) — VC Fund, 6 deals together
- [Atlante Ventures](https://shizune.co/investors/profile/atlante-ventures) — VC Fund, 2 deals together
- [Como Venture](https://shizune.co/investors/profile/como-venture) — VC Fund, 2 deals together
- [3LB Seed Capital Srl](https://shizune.co/investors/profile/3lb-seed-capital-srl) — VC Fund, 1 deal together
- [Fondamenta SGR](https://shizune.co/investors/profile/fondamenta-sgr) — VC Fund, 1 deal together
- [Fondo Italiano d'Investimento](https://shizune.co/investors/profile/fondo-italiano-di-investimento) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [CDP Venture Capital](https://shizune.co/investors/profile/cdp-venture-capital) — VC Fund
- [Club degli Investitori](https://shizune.co/investors/profile/club-degli-investitori) — VC Fund
- [Primo Capital](https://shizune.co/investors/profile/barcamper-ventures) — VC Fund

## Featured in investor lists
- [All VC Funds in Italy](https://shizune.co/investors/vc-funds-italy)
- [All Investors in Italy](https://shizune.co/investors/investors-italy)
- [Software VC Funds in Italy](https://shizune.co/investors/software-vc-funds-italy)
- [Biotechnology Investors in Italy](https://shizune.co/investors/biotechnology-investors-italy)
- [Biotechnology VC Funds in Italy](https://shizune.co/investors/biotechnology-vc-funds-italy)
- [Enterprise Investors in Italy](https://shizune.co/investors/enterprise-investors-italy)

## FAQ

### What does Green Arrow Capital invest in?

Green Arrow Capital invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 10 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Green Arrow Capital's check size?

Green Arrow Capital typically joins rounds of $1.5M–$2.2M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Green Arrow Capital participates in.

### How do I contact Green Arrow Capital?

Public channels for Green Arrow Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Green Arrow Capital?

The team at Green Arrow Capital includes Daniele Camponeschi (Co-Founder & Chief Investment Officer), Eugenio de Blasio (Founder, main shareholder and Group CEO) and Walter Ricciotti (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co